Haibo F. Wang

59 Haier Road
Qingdao, 266000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Seroprevalence and risk factors for Toxoplasma gondii infection in women with breast tumors in Eastern China.

Seroprevalence and risk factors for Toxoplasma gondii infection in women with breast tumors in Eastern China.

Journal: American journal of translational research

Published: March 25, 2026

Adipocyte-rich microenvironment promotes TNBC progression through SIRT6-associated ACSL5 dysregulation and lipid storage-associated phenotypes.

Adipocyte-rich microenvironment promotes TNBC progression through SIRT6-associated ACSL5 dysregulation and lipid storage-associated phenotypes.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 09, 2026

Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer: a multicentre study in mainland China and Hong Kong.

Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer: a multicentre study in mainland China and Hong Kong.

Journal: Breast (Edinburgh, Scotland)

Published: February 06, 2026

Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY study.

Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY study.

Journal: Breast (Edinburgh, Scotland)

Published: November 28, 2025

Chinese expert consensus on endocrine therapy for breast cancer (2026 edition).

Chinese expert consensus on endocrine therapy for breast cancer (2026 edition).

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer

Published: November 19, 2025

Development and validation of a nomogram for predicting bone metastasis in breast cancer: a retrospective study.

Development and validation of a nomogram for predicting bone metastasis in breast cancer: a retrospective study.

Journal: Frontiers in surgery

Published: October 11, 2025

Evaluation of oncologic safety and clinical effectiveness of immediate autologous fat grafting in breast-conserving surgery: a multicenter, prospective, randomized controlled clinical trial for breast cancer.

Evaluation of oncologic safety and clinical effectiveness of immediate autologous fat grafting in breast-conserving surgery: a multicenter, prospective, randomized controlled clinical trial for breast cancer.

Journal: International journal of surgery (London, England)

Published: August 24, 2025

The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina study.

The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina study.

Journal: International journal of clinical oncology

Published: July 25, 2025

DESTINY-Breast09, new breakthroughs in first-line therapy for HER2-positive advanced breast cancer.

DESTINY-Breast09, new breakthroughs in first-line therapy for HER2-positive advanced breast cancer.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer

Published: June 27, 2025

Pretreatment MRI-Based Radiomics for Predicting Recurrence and Disease-Free Survival in Young Women With Breast Cancer After Neoadjuvant Chemotherapy.

Pretreatment MRI-Based Radiomics for Predicting Recurrence and Disease-Free Survival in Young Women With Breast Cancer After Neoadjuvant Chemotherapy.

Journal: Journal of computer assisted tomography

Published: May 18, 2025

Neural Responsiveness to Electrical Stimulation in Children With Common Cavity Deformity.

Neural Responsiveness to Electrical Stimulation in Children With Common Cavity Deformity.

Journal: Laryngoscope investigative otolaryngology

Published: March 23, 2025

Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.

Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.

Journal: Signal transduction and targeted therapy

Published: February 24, 2025

Showing 1-12 of 85

Last Updated: 09/26/2026